Search Results - "Huebner, Gerdt"
-
1
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP
Published in British journal of cancer (16-02-2021)“…Background Patients with carcinoma of unknown primary (CUP) have a dismal prognosis, even when treated with multi-agent chemotherapy. We hypothesised that…”
Get full text
Journal Article -
2
Case report: Tenosynovial giant cell tumor
Published in Frontiers in oncology (26-09-2024)“…Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring…”
Get full text
Journal Article -
3
Up-Front Tandem High-Dose Chemotherapy Compared With Standard Chemotherapy With Doxorubicin and Paclitaxel in Metastatic Breast Cancer: Results of a Randomized Trial
Published in Journal of clinical oncology (20-01-2005)“…The role of high-dose chemotherapy (HDCT) in metastatic breast cancer remains controversial. Trials with late intensification HDCT have failed to show an…”
Get full text
Journal Article -
4
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
Published in Nature communications (24-10-2023)“…Cancer of unknown primary has a dismal prognosis, especially following failure of platinum-based chemotherapy. 10-20% of patients have a high tumor mutational…”
Get full text
Journal Article -
5
Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 4120 Background: Paclitaxel/carboplatin is one of the standard regimens for empiric treatment of patients (pts) with carcinoma with unknown…”
Get full text
Journal Article -
6
Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial
Published in Cancer (15-05-2015)“…BACKGROUND The objective of this study was to evaluate the efficacy of belinostat, a histone deacetylase inhibitor, when added to paclitaxel/carboplatin in the…”
Get full text
Journal Article -
7
Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome
Published in Deutsches Ärzteblatt international (01-10-2008)“…The term cancer of unknown primary site (CUP) syndrome is used to describe malignancies in which a complete diagnostic work-up detects metastases in the…”
Get full text
Journal Article -
8
Comparison of histopathological and gene expression-based typing of cancer of unknown primary
Published in Virchows Archiv : an international journal of pathology (01-01-2010)“…For the clinical diagnosis and appropriate therapy of patients with cancer of unknown primary (CUP), biopsies of the tumor metastases are generally examined…”
Get full text
Journal Article -
9
Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary
Published in Onkologie (01-04-2009)“…Carcinomas of unknown primary (CUP) account for approximately 2-5% of all cancer diagnoses. Except for some subsets with favorable prognosis, for most of these…”
Get more information
Journal Article -
10
Carcinoma of Unknown Primary – an Orphan Disease?
Published in Breast care (Basel, Switzerland) (2008)“…Carcinoma of unknown primary (CUP) is an intriguing clinical finding that is defined as biopsy-proven metastasis from a malignancy in the absence of an…”
Get full text
Journal Article -
11
Effect of All Transretinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia. Results of a Multicenter Randomized Trial
Published in Blood (01-12-1993)“…We designed a multicenter randomized trial comparing chemotherapy with daunorubicin-Ara C (chemotherapy group) and all transretinoic acid (ATRA) combined to…”
Get full text
Journal Article -
12
Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation
Published in Transplantation (27-08-2000)“…Myelodysplastic syndrome and acute myelogenous leukemia secondary to radiotherapy, radiation exposure, and chemotherapy is a well-documented malignant stem…”
Get full text
Journal Article -
13
-
14
Tumorerkrankung mit unbekanntem Primarius
Published in Im Fokus Onkologie (01-04-2017)Get full text
Journal Article -
15
Metastases in the Absence of a Primary Tumor
Published in Deutsches Ärzteblatt international (24-10-2008)Get full text
Journal Article